Moneta Group Investment Advisors Has Increased Holding in Boston Scientific (BSX); Central Bank & Trust Co Lowered Its Holding in Hologic (HOLX) as Share Value Declined

April 21, 2018 - By Moses P. Lee

Boston Scientific Corporation (NYSE:BSX) Logo

Kelly Cardwell decreased its stake in Hologic Incorporated (HOLX) by 35.36% based on its latest 2017Q4 regulatory filing with the SEC. Central Bank & Trust Co sold 9,373 shares as the company’s stock declined 13.23% with the market. The hedge fund run by Kelly Cardwell held 17,132 shares of the health care company at the end of 2017Q4, valued at $732,000, down from 26,505 at the end of the previous reported quarter. Central Bank & Trust Co who had been investing in Hologic Incorporated for a number of months, seems to be less bullish one the $10.59 billion market cap company. The stock decreased 0.80% or $0.31 during the last trading session, reaching $38.3. About 1.19M shares traded. Hologic, Inc. (NASDAQ:HOLX) has declined 11.91% since April 21, 2017 and is downtrending. It has underperformed by 23.46% the S&P500.

Moneta Group Investment Advisors Llc increased its stake in Boston Scientific Corp (BSX) by 767.82% based on its latest 2017Q4 regulatory filing with the SEC. Moneta Group Investment Advisors Llc bought 80,160 shares as the company’s stock rose 7.69% while stock markets declined. The institutional investor held 90,600 shares of the medical and dental instruments company at the end of 2017Q4, valued at $2.25M, up from 10,440 at the end of the previous reported quarter. Moneta Group Investment Advisors Llc who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $39.79 billion market cap company. The stock decreased 0.17% or $0.05 during the last trading session, reaching $28.84. About 8.66 million shares traded or 15.70% up from the average. Boston Scientific Corporation (NYSE:BSX) has risen 9.97% since April 21, 2017 and is uptrending. It has underperformed by 1.58% the S&P500.

Analysts await Hologic, Inc. (NASDAQ:HOLX) to report earnings on May, 2 after the close. They expect $0.53 earnings per share, up 6.00% or $0.03 from last year’s $0.5 per share. HOLX’s profit will be $146.56 million for 18.07 P/E if the $0.53 EPS becomes a reality. After $0.55 actual earnings per share reported by Hologic, Inc. for the previous quarter, Wall Street now forecasts -3.64% negative EPS growth.

Since February 13, 2018, it had 3 insider buys, and 1 insider sale for $682,999 activity. Wendell Amy McBride also bought $199,826 worth of Hologic, Inc. (NASDAQ:HOLX) on Wednesday, March 14. Shares for $271,250 were sold by Bebo Allison P on Friday, March 16. Shares for $250,023 were bought by Nawana Namal.

Investors sentiment decreased to 0.74 in Q4 2017. Its down 0.14, from 0.88 in 2017Q3. It fall, as 57 investors sold HOLX shares while 165 reduced holdings. 70 funds opened positions while 94 raised stakes. 264.36 million shares or 0.45% less from 265.54 million shares in 2017Q3 were reported. Guardian Life Of America stated it has 912 shares or 0.01% of all its holdings. The Japan-based Sumitomo Mitsui Asset Com Limited has invested 0.01% in Hologic, Inc. (NASDAQ:HOLX). North Star Inv Management stated it has 400 shares. Advisors Asset Management owns 15,693 shares. Strs Ohio owns 31,183 shares or 0.01% of their US portfolio. Motco accumulated 0% or 76 shares. Louisiana State Employees Retirement Sys holds 0.03% of its portfolio in Hologic, Inc. (NASDAQ:HOLX) for 16,700 shares. 1,000 are held by Css Limited Liability Corporation Il. Altfest L J And Company Inc holds 13,737 shares. Jpmorgan Chase Co holds 0.01% or 665,033 shares in its portfolio. Rmb Cap Mgmt Ltd Liability Co invested in 6,351 shares. Pura Vida Ltd Limited Liability Company reported 90,000 shares. Balyasny Asset Mngmt Limited Liability owns 798,313 shares. Rock Springs Capital Mngmt Limited Partnership holds 335,000 shares or 0.65% of its portfolio. Utd Capital Advisers Lc holds 4,757 shares.

Among 18 analysts covering Hologic (NASDAQ:HOLX), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Hologic had 57 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Hologic, Inc. (NASDAQ:HOLX) has “Buy” rating given on Monday, January 8 by Piper Jaffray. The rating was upgraded by Stifel Nicolaus to “Buy” on Friday, December 11. The firm has “Hold” rating given on Friday, January 19 by Deutsche Bank. The rating was maintained by Barclays Capital with “Overweight” on Thursday, August 3. The rating was downgraded by Evercore on Wednesday, January 4 to “Hold”. As per Wednesday, July 5, the company rating was maintained by Needham. The stock of Hologic, Inc. (NASDAQ:HOLX) has “Buy” rating given on Thursday, August 3 by Canaccord Genuity. The firm earned “Buy” rating on Wednesday, February 15 by Needham. The stock of Hologic, Inc. (NASDAQ:HOLX) earned “Buy” rating by BTIG Research on Monday, October 26. The stock of Hologic, Inc. (NASDAQ:HOLX) has “Hold” rating given on Thursday, August 3 by Cowen & Co.

Central Bank & Trust Co, which manages about $414.64 million US Long portfolio, upped its stake in Vanguard Emerg Mkts Gov Bnd (VWOB) by 8,953 shares to 53,448 shares, valued at $4.29 million in 2017Q4, according to the filing. It also increased its holding in Parker Hannifin Corp (NYSE:PH) by 18,031 shares in the quarter, for a total of 18,195 shares, and has risen its stake in Ishares Tr Core Us Aggbd Et (AGG).

Investors sentiment increased to 1.34 in Q4 2017. Its up 0.30, from 1.04 in 2017Q3. It increased, as 36 investors sold BSX shares while 158 reduced holdings. 86 funds opened positions while 174 raised stakes. 1.18 billion shares or 2.38% less from 1.21 billion shares in 2017Q3 were reported. Commonwealth Bancshares Of Aus has invested 0.02% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Liberty Mutual Grp Asset Mngmt reported 54,688 shares or 0.04% of all its holdings. Hsbc Holdg Public Ltd Liability Corporation invested in 1.33 million shares. Orbimed Advsrs Ltd Company invested 3.26% of its portfolio in Boston Scientific Corporation (NYSE:BSX). The New York-based Braun Stacey Associate Incorporated has invested 0.59% in Boston Scientific Corporation (NYSE:BSX). Ahl Partners Llp holds 177,037 shares. Wade G W holds 0.04% in Boston Scientific Corporation (NYSE:BSX) or 13,063 shares. Pnc Fincl Services Gru Inc invested 0% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Private Wealth accumulated 286,395 shares or 1.31% of the stock. D Scott Neal Incorporated invested in 1,200 shares or 0.02% of the stock. 12.66M are held by Goldman Sachs Gru. Moors And Cabot reported 50,018 shares. American Century stated it has 0.17% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Meag Munich Ergo Kapitalanlagegesellschaft Mbh reported 65,713 shares. Bank Of America Corp De has 0.03% invested in Boston Scientific Corporation (NYSE:BSX) for 7.79M shares.

Moneta Group Investment Advisors Llc, which manages about $13.82B and $661.19M US Long portfolio, decreased its stake in Novo (NYSE:NVO) by 15,000 shares to 55,300 shares, valued at $2.97M in 2017Q4, according to the filing. It also reduced its holding in At&T Inc Com (NYSE:T) by 17,632 shares in the quarter, leaving it with 59,154 shares, and cut its stake in General Electric Co Com (NYSE:GE).

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Moses P. Lee

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts